Motion sickness

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Retrieved on: 
星期三, 四月 3, 2024
Aircraft, EST, Culture, Shipyard, Motion sickness, Prestige Consumer Healthcare, History, News, Life, Nausea, Exhibition, Invention, Collection

TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine® .

Key Points: 
  • TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine® .
  • Dramamine and barf bags have been fighting the good fight against nausea together, but the barf bag can make way for a purpose that goes way beyond catching upchucks.
  • Each bag in its repurposed form will be available for purchase for $5, and bundles including a barf bag and Dramamine product will be $10 while supplies last.
  • Consumers can pay their tributes to the barf bag’s cultural impact and secure their piece of barf bag history by visiting TheLastBarfBag.com .

VRAL Games, a New Gaming Company Focused on Virtual Reality, Launches at the Game Developers Conference 2024

Retrieved on: 
星期二, 三月 19, 2024
Technology, Electronic Games, Entertainment, Other Technology, Research, Physics, GDC, Conference, Motion sickness, Superbike World Championship, FIM, XR, Oculus Quest, Publishing, Artificial intelligence, AI, Steam, IP, Machine learning, Video game

VRAL Games , a new games publisher and developer focused on virtual (VR) and extended reality (XR), is making its debut at this year’s Game Developers Conference (GDC) in San Francisco.

Key Points: 
  • VRAL Games , a new games publisher and developer focused on virtual (VR) and extended reality (XR), is making its debut at this year’s Game Developers Conference (GDC) in San Francisco.
  • Founded by seasoned experts in gaming, hardware and AI, VRAL’s mission is to build the future of immersive games.
  • Its initial game releases will focus on a fusion of innovative gameplay, proprietary technology, and social engagement.
  • Its platform and original IP aims to combine advancements in artificial intelligence (AI), gaming software and virtual controls.

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Retrieved on: 
星期三, 四月 3, 2024
Aircraft, EST, Culture, Shipyard, Motion sickness, NBC, Prestige Consumer Healthcare, History, News, Life, Nausea, Exhibition, Invention, Collection

TARRYTOWN, N.Y., April 3, 2024 /PRNewswire/ -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief, but as Dramamine has risen in popularity, the use of barf bags has sadly diminished. To commemorate the joint anniversary, Dramamine® is breathing new life – not barf – into the paper product with a mission to save its fellow partner in puke.

Key Points: 
  • The documentary short film, The Last Barf Bag: A Tribute to a Cultural Icon , explores the cultural impact of a humble but crucially useful American invention.
  • Dramamine and barf bags have been fighting the good fight against nausea together, but the barf bag can make way for a purpose that goes way beyond catching upchucks.
  • "I use a lot of unorthodox materials in my work, but a barf bag is a first!
  • Consumers can pay their tributes to the barf bag's cultural impact and secure their piece of barf bag history by visiting TheLastBarfBag.com .

AjnaLens Unveils Groundbreaking High Performance Spatial Computing at GDC 2024

Retrieved on: 
星期二, 三月 26, 2024
GDC, Conference, Motion sickness, VR, Intelligence, SAN, Integration, AI, Unreal Engine, Privacy, Ray tracing, Extended reality, IEEE Security & Privacy, Virtual reality, Video game

Introducing AjnaHPSC (High Performance Spatial Computing), an XR streaming solution – the most significant breakthrough in XR technology in 10 years.

Key Points: 
  • Introducing AjnaHPSC (High Performance Spatial Computing), an XR streaming solution – the most significant breakthrough in XR technology in 10 years.
  • Besides the hardware, running high quality content requires high bandwidth, which if not achieved, leads to streaming lags or latency.
  • As AjnaLens continues to push the boundaries of spatial computing, the future of XR has never looked brighter.
  • AjnaLens aims to augment human intelligence and transform human life from a journey of prosperity to self actualisation."

Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults

Retrieved on: 
星期二, 一月 30, 2024
Nausea, Motion sickness, CRL, FDA, Food, Motion, Symantec Endpoint Protection, Vomiting, NDA, Scopolamine, Pharmaceutical industry

ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company’s New Drug Application (NDA) for intranasal scopolamine (DPI-386) for the prevention of nausea and vomiting induced by motion in adults.

Key Points: 
  • ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company’s New Drug Application (NDA) for intranasal scopolamine (DPI-386) for the prevention of nausea and vomiting induced by motion in adults.
  • “Following our review of the CRL, we plan on scheduling a formal meeting with the FDA to fully understand the issues raised in the CRL so we can develop and implement a comprehensive action plan,” said Barry I. Feinberg, M.D., President & CEO of Defender Pharmaceuticals.
  • “We remain confident that our intranasal scopolamine is a safe and effective therapy for the prevention of motion sickness, and we will work closely with the FDA to ensure that we can bring this innovative new product to the market.”

VMocion announces $3M seed round to advance its virtual motion technologies

Retrieved on: 
星期三, 一月 3, 2024
Atmosphere, Car, Travel, Research, Human factors and ergonomics, Fatigue, Brain, Aircraft, Health, Human, Education, XR, Motion, Motion sickness, Perception, Mayo Clinic, HMDS, EV, Road

SCOTTSDALE, Ariz., Jan. 3, 2024 /PRNewswire/ -- VMocion, an entertainment technology company in Scottsdale, Arizona, announced today a $3M seed round for advancement of its VMocion 3V™ and WAIV™ technologies.

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 3, 2024 /PRNewswire/ -- VMocion, an entertainment technology company in Scottsdale, Arizona, announced today a $3M seed round for advancement of its VMocion 3V™ and WAIV™ technologies.
  • VMocion's 3V™ technologies allow users to feel the motion they see.
  • A virtually stimulated sense of physical motion matches the motion seen on screen, creating an all-sensory experience.
  • Motion sickness occurs when humans feel motion without seeing that matching motion.

Hyundai Mobis to Assist Marine Corps in Reducing Motion Sickness in Armored Vehicles

Retrieved on: 
星期四, 十二月 28, 2023
KRX, Smell, Travel, Transport, Heart rate, Movement, Software, System, Build automation, MOU, Analysis, Hyundai, Motion sickness, Motion Sickness, Posture, Aviation, Cognitive Technologies, Hearing, Road

Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.

Key Points: 
  • Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.
  • Importantly, this marks the first application of Hyundai Mobis's motion sickness reduction technology in the broader mobility sector beyond conventional vehicles.
  • Hyundai Mobis confirmed that this technology can prevent motion sickness by up to 70% and reduce the symptoms by 40%.
  • Hyundai Mobis will provide the Marine Corps with an integrated motion sickness reduction solution tailored for harsh environments, combining hardware and software.

Hyundai Mobis to Assist Marine Corps in Reducing Motion Sickness in Armored Vehicles

Retrieved on: 
星期四, 十二月 28, 2023
KRX, Smell, Travel, Transport, Heart rate, Movement, Software, System, Build automation, MOU, Analysis, Hyundai, Motion sickness, Motion Sickness, Posture, Aviation, Cognitive Technologies, Hearing, Road

Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.

Key Points: 
  • Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.
  • Importantly, this marks the first application of Hyundai Mobis's motion sickness reduction technology in the broader mobility sector beyond conventional vehicles.
  • Hyundai Mobis confirmed that this technology can prevent motion sickness by up to 70% and reduce the symptoms by 40%.
  • Hyundai Mobis will provide the Marine Corps with an integrated motion sickness reduction solution tailored for harsh environments, combining hardware and software.

Vetster and Air Canada’s First-of-its-Kind Partnership Unleashes an Innovative Era of On-the-Go Pet Care

Retrieved on: 
星期二, 十二月 12, 2023
Veterinary, Air, Pets, Transport, Telemedicine, Virtual Medicine, Transportation, Health, Consumer, Travel, Pet, Vetster, Safety, MIA, ORD, Atmosphere of Earth, LAX, Air Canada Cargo, Animal, Operational excellence, Dehydration, Partnership, Atmosphere, Communication, Motion sickness, Parent, Air Canada, Bottled water

Vetster, the world's fastest growing veterinary telehealth and pet care marketplace, today announced its partnership with Air Canada to provide around-the-clock access to Vetster’s virtual veterinary services for pets traveling in cargo.

Key Points: 
  • Vetster, the world's fastest growing veterinary telehealth and pet care marketplace, today announced its partnership with Air Canada to provide around-the-clock access to Vetster’s virtual veterinary services for pets traveling in cargo.
  • Vetster aims to set a new standard for quality care, safety and peace of mind for millions of traveling pet parents.
  • Trained Air Canada personnel can now use Vetster on behalf of pet parents to connect with licensed veterinarians, who can support pets traveling in cargo and in need of medical assistance.
  • Pet parents are looking for transparent, effective and timely care for their pets when flying,” said Mark Bordo, CEO and Co-Founder of Vetster.

WAT Medical Joins World's Largest Boat Show

Retrieved on: 
星期三, 十二月 13, 2023
Vomiting, Wang, Health Canada, TGA, NMPA, Electronics, Patient, Multimedia, Ohio State University, FDA, CE, Anesthesiology, University, Nausea, Trial of the century, Motion sickness, Motion, PONV, Vagus nerve, Amazon

VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show.

Key Points: 
  • VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show.
  • WAT Medical is a Canadian company that develops wearable medical technologies.
  • WAT Medical has partnered with VIKAND since the 2019 Seatrade Cruise Global conference to further expand EmeTerm's market.
  • British Journal of Anesthesiology
    View original content to download multimedia: https://www.prnewswire.com/news-releases/wat-medical-joins-worlds-larges...
    SOURCE WAT Medical Enterprise Ltd.